Sugi Predict

Sugi Predict / Compounds / SCHEMBL1851950

SCHEMBL1851950

SCHEMBL1851950

CCNc1ccc(Nc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.62
▸ HSD17B10 Q99714 5/20 0.62
▸ ALOX12 P18054 5/20 0.62
▸ L3MBTL1 Q9Y468 3/20 0.62
▸ ALOX15 P16050 3/20 0.62
▸ TSHR P16473 3/20 0.62
▸ TDP1 Q9NUW8 2/20 0.62
▸ MAPK1 P28482 2/20 0.62
▸ PTGS1 P23219 1/20 0.62
▸ SLC6A2 P23975 1/20 0.62
▸ PTGS2 P35354 1/20 0.62
▸ HTR2B P41595 1/20 0.62
▸ LMNA P02545 2/20 0.59
▸ HPGD P15428 3/20 0.56
▸ MAPT P10636 9/20 0.52
▸ GAA P10253 2/20 0.52
▸ CYP3A4 P08684 4/20 0.50
▸ ADRA2A P08913 2/20 0.50
▸ THRB P10828 1/20 0.50
▸ RECQL P46063 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709 0.90 — —
SCHEMBL4916223 0.90 LMNA (0.61) ALDH1A1HSD17B10ALOX12L3MBTL1ALOX15
SCHEMBL20852333 0.90 LMNA (0.61) ALDH1A1HSD17B10ALOX12L3MBTL1ALOX15
SCHEMBL22995575 0.88 HTT (0.56) ALDH1A1HSD17B10ALOX12L3MBTL1ALOX15
Ethane SCHEMBL29007244 0.87 LMNA (0.59) ALDH1A1HSD17B10L3MBTL1TSHRTDP1
Ammonia Solution, Strong SCHEMBL8429752 0.87 LMNA (0.59) ALDH1A1HSD17B10L3MBTL1TSHRTDP1
Water SCHEMBL9462188 0.87 LMNA (0.59) ALDH1A1HSD17B10L3MBTL1TSHRTDP1
Iodide SCHEMBL17710408 0.87 LMNA (0.59) ALDH1A1HSD17B10L3MBTL1TSHRTDP1
SCHEMBL29961278 0.87 LMNA (0.59) ALDH1A1HSD17B10L3MBTL1TSHRTDP1
SCHEMBL9573532 0.87 LMNA (0.59) ALDH1A1HSD17B10L3MBTL1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976821-B1 DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE CHEMTURA CORP (US) 2011-05-25 — — EP claimed
EP-1976821-A1 DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE CHEMTURA CORPORATION (US) 2008-10-08 — — EP claimed
US-7361788-B2 Direct alkylation of N-alkyl-N′-phenyl-p-phenylenediamine CHEMTURA CORPORATION (US) 2008-04-22 — — US claimed
WO-2007087195-A1 DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE CHEMTURA CORPORATION (US) 2007-08-02 — — WO claimed
US-20070173668-A1 Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine LANXESS SOLUTIONS US INC. 2007-07-26 — — US claimed
EP-1056711-B1 PROCESS FOR STABILISING (METHA)ACRYLIC ESTERS AGAINST UNWANTED RADICAL POLYMERISATION BASF AG (DE) 2004-10-06 — — EP claimed
EP-4028382-B1 QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD ECOLAB USA INC (US) 2023-11-22 — — EP disclosed
WO-2023028524-A1 NEW ANTIDEGRADANTS BASED ON FATTY ACIDS OR DERIVATIVES FUNCTIONALIZED WITH PHENYLENEDIAMINES FLEXSYS AMERICA L.P. (US) 2023-03-02 — — WO disclosed
US-11396629-B2 Quinone methide and ammonium salt antipolymerant composition and method ECOLAB USA INC. (US) 2022-07-26 — — US disclosed
CN-114502522-A Methylated quinone and ammonium salt anti-polymerization agent compositions and methods 埃科莱布美国股份有限公司 2022-05-13 — — CN disclosed
US-20210115489-A1 NOVEL MEDIATOR KIKKOMAN CORPORATION (JP) 2021-04-22 — — US disclosed
US-20210115489-A1 NOVEL MEDIATOR KIKKOMAN CORPORATION (JP) 2021-04-22 — — US disclosed
US-20210108141-A1 QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD ECOLAB USA INC. 2021-04-15 — — US disclosed
US-4797504-A HYDROXYLAMINES AND PHENYLENEDIAMINE DERIVATIVES BETZ LABORATORIES, INC. (US) 1989-01-10 — — US disclosed
EP-0266906-A2 Method and composition for inhibiting acrylate ester polymerization BETZ EUROPE, INC. (US) 1988-05-11 — — EP disclosed
US-4720566-A Method and composition for inhibiting acrylonitrile polymerization BETZ LABORATORIES, INC. (US) 1988-01-19 — — US disclosed
US-4087619-A Amine containing antioxidants THE GOODYEAR TIRE & RUBBER COMPANY (US) 1978-05-02 — — US disclosed
US-4051067-A Stabilization of unsaturated carboxylic acid esters with mixtures of polyalkyleneamines and arylenediamines MONSANTO COMPANY (US) 1977-09-27 — — US disclosed
US-4016198-A Stabilization of unsaturated carboxylic acid esters with mixtures of polyalkylene-amines and arylenediamines MONSANTO COMPANY (US) 1977-04-05 — — US disclosed
US-3979436-A ACRYLIC ESTERS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173668-A1 Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine PNMT, AAAS, PNN ALDH1A1 663/4885HSD17B10 2077/4885ALOX12 11/4885
US-20210115489-A1 NOVEL MEDIATOR MPO, EPX, LPO ALDH1A1 1833/4885HSD17B10 705/4885ALOX12 289/4885
US-11396629-B2 Quinone methide and ammonium salt antipolymerant composition and method SQOR, QDPR, NQO2 ALDH1A1 961/4885HSD17B10 1224/4885ALOX12 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.